The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
craigy...I think we need to start you on half a gummie, then next week maybe a full one !! : )
nice buys starting to roll in now...
CitiM, i love the dream that we occasionally fall into, great to see your car and yacht interest, after the ferrari i’ve also looked at yachts and a property on an ocean drive either in malibu or santa Mon! LOL LOL £5 plus PLEASE!
If you don't need the money at present then you need to ask yourself which would hurt you more - leaving the money invested and the SP dropping 20% (which here looks unlikely) or taking the money out now and watching the SP rise 20%. Either scenario could happen and what's right for one person may not be right for another. I hope your decision works out well for you either way
Hi Craig,
I have (still...) has good memory but I do many times write important things as it's often help to register and digest.....
As for not sure what is right to do (buy or sell....) I don't think right is the word simply because folks can have valid reasons to sell, ie, pay debt, holiday, buy a car or a van...etc, if you have a decent profit even for the sake of hedging your bets this can't be a bad move for sure.....
Basically it's very individual choice.
Good luck with whatever you do mate.
Trying not to get ahead of myself with potential sp’s (staying off Aston Martin and yacht websites), so just looking forward to the next rn and see what happens.
It is almost a certainty that a tobacco group will buy ZOE, I just hope its not too soon, we need a year or two to get our shares to a sensible level like £25.
It was mentioned here before, and although a long shot there is a small chance of one of the big tobacco companies putting a very attractive take over offer to us in order to balance their books for potentially lost of substantial revenue from the likes of us.....it's a BIG IF atm but could be a reason for another jump for us....just my thoughts anyway....
GLA.
Zoetic International plc (LSE: ZOE), the London-listed vertically integrated CBD and natural resources company, is pleased to announce that it has filed US patent applications for its method of manufacturing of its Chill brand of THC-free, smokable CBD products (the "Patent"). This patent-pending method also includes a variation smoking cessation product, employing combinations of nicotine and CBD, which is also THC-free. The Patent has been in development by the Company for over a year.
The Company believes that CBD may play a rapidly increasing role in smoking cessation aides, and that its Chill branded tobacco-free, THC-free and nicotine-free products are well-placed to take an increasing share of this market, and that the Patent will provide the Company, if it is issued, with a protected market-leading offering. The Smoking Cessation market was estimated to be worth around $4 bn in 2019 in the USA, with significant growth forecast (Source: Grand View Research).